Clinical Trial: Impact of New Hormonotherapy Drugs in Prostatic Cancer on the Risk of Cardiovascular Events : a Pharmacoepidemiology Study Using the French Health Care Claims Database
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Prostate Cancer
Study Type: OBSERVATIONAL
Official Title: Impact of Androgen Receptor Signaling Inhibitors on Cardiovascular Events in Prostate Cancer: a Pharmacoepidemiology Study Using the French Health Care Claims Database
Brief Summary:
In prostate cancer, whether advanced or localized, hormone therapy is a key treatment.These therapies work by lowering male hormone levels to slow the growth of cancer.More recently, a new group of medications called Androgen Receptor Signaling Inhibitors (ARSIs) has been introduced.These drugs are used alongside standard hormone therapy and are now prescribed for both advanced and high-risk localized prostate cancer.There are two main types of ARSIs: abiraterone acetate, which blocks the body from making…
Read more